Y, H., T, Z., S, T., Y, T., X, W., Z, L., . . . G, D. (2025). KRT23 as a Potential Target for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): Evidence From Bioinformatics Analysis, Human Gene Polymorphism and Animal Experiments. Dove Medical Press.
Chicago Style (17th ed.) CitationY, Hao, et al. KRT23 as a Potential Target for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): Evidence From Bioinformatics Analysis, Human Gene Polymorphism and Animal Experiments. Dove Medical Press, 2025.
MLA (9th ed.) CitationY, Hao, et al. KRT23 as a Potential Target for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): Evidence From Bioinformatics Analysis, Human Gene Polymorphism and Animal Experiments. Dove Medical Press, 2025.
Warning: These citations may not always be 100% accurate.